Lexapro (Escitalopram) Dosing
For adults with major depressive disorder or generalized anxiety disorder, start Lexapro at 10 mg once daily, which is both the initial and recommended maintenance dose, with a maximum of 20 mg daily if needed after at least 1 week. 1
Adult Dosing
Major Depressive Disorder (MDD)
- Initial dose: 10 mg once daily
- Recommended dose: 10 mg once daily
- Maximum dose: 20 mg once daily
- Titration interval: Increase after minimum 1 week if needed
- Key consideration: Fixed-dose trials showed 10 mg and 20 mg both effective, but 20 mg did not demonstrate greater benefit over 10 mg 1
Generalized Anxiety Disorder (GAD)
- Initial dose: 10 mg once daily
- Recommended dose: 10 mg once daily
- Maximum dose: 20 mg once daily
- Titration interval: Increase after minimum 1 week if needed 1
Pediatric Dosing
Adolescents (12+ years) with MDD
- Initial dose: 10 mg once daily
- Recommended dose: 10 mg once daily
- Maximum dose: 20 mg once daily
- Titration interval: Increase after minimum 3 weeks (longer than adults) 1
Children (7+ years) with GAD
- Initial dose: 10 mg once daily
- Recommended dose: 10 mg once daily
- Maximum dose: 20 mg once daily
- Titration interval: Increase after minimum 2 weeks 1
Important: Lexapro is NOT approved for children under 7 years of age 1
Special Populations
Elderly Patients
The recommended dose for elderly patients is 10 mg once daily—do not routinely increase to 20 mg 1. This reflects age-related decreases in drug clearance 2. Research shows elderly patients, particularly those over 65, have reduced escitalopram clearance and are at higher risk for adverse effects at standard doses 3, 2.
Hepatic Impairment
The recommended dose is 10 mg once daily 1. Do not exceed this dose in patients with hepatic dysfunction.
Renal Impairment
- Mild to moderate impairment: No dose adjustment needed
- Severe impairment (CrCl <20 mL/min): Recommended dosage not established 1
Administration Details
- Timing: Once daily, morning or evening (patient preference)
- Food: May take with or without food
- Steady state: Achieved within 7-10 days 4
- Half-life: 27-33 hours, supporting once-daily dosing 4
Critical Prescribing Considerations
CYP2C19 Poor Metabolizers
While not required for routine prescribing, be aware that CYP2C19 poor metabolizers have 2-fold higher escitalopram exposure 5, 2. Consider maintaining these patients at 10 mg daily, as they may experience therapeutic effects at lower doses and higher risk of adverse effects at 20 mg 5.
Discontinuation
Taper gradually whenever possible rather than abrupt cessation 1. Escitalopram has relatively lower risk of discontinuation syndrome compared to shorter-acting SSRIs like paroxetine, but symptoms can still occur 6. Reduce dose over 10-14 days minimum when stopping 7.
MAOI Interactions
Allow 14 days between discontinuing an MAOI and starting escitalopram, and vice versa 1. This is a contraindication due to serotonin syndrome risk.
Screening Before Initiation
Screen all patients for personal or family history of bipolar disorder, mania, or hypomania before starting 1. Antidepressants can precipitate manic episodes in susceptible individuals.
Common Pitfalls
Avoid premature dose escalation: Many patients respond adequately to 10 mg daily. The 20 mg dose did not show superior efficacy in controlled trials 1
Don't exceed 10 mg in elderly patients: Age-related pharmacokinetic changes increase exposure and adverse effect risk 1, 3, 2
Monitor for activation/agitation early: Initial adverse effects can include anxiety or agitation, particularly in the first 1-2 weeks 6
Allow adequate trial duration: Full therapeutic response requires 4-8 weeks at therapeutic dose 7. Assess response before increasing dose.
Watch for suicidality in young patients: Black box warning for increased suicidal thoughts/behaviors in patients under 25 years 1